Latest Triple-negative breast cancer Stories
Results presented at American Association of Cancer Research Annual Meeting 2015, Philadelphia, April 18-22 PHILADELPHIA, April 22, 2015 /PRNewswire/ -- Researchers at the Cancer Research
ROCKVILLE, Md., March 25, 2015 /PRNewswire/ -- CASI Pharmaceuticals, Inc.
The use of combination targeted therapies will improve progression-free disease as well as survival rates, finds Frost & Sullivan LONDON, March 17, 2015 /PRNewswire/ -- Despite the availability
WOONSOCKET, R.I., March 12, 2015 /PRNewswire/ -- MultiCell Immunotherapeutics, Inc. (MCIT), a majority owned subsidiary of MultiCell Technologies, Inc.
TAMPA, Fla., March 12, 2015 /PRNewswire/ -- Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc.
Investment bolsters immediate capital needs for progressing clinical programs SEATTLE, March 10, 2015 /PRNewswire/ -- TapImmune,
WORCESTER, Mass. and TORONTO, Feb.
Clinical Trials for Breast Cancer Vaccine to Begin in 2015 on Florida's First Coast JACKSONVILLE, Fla., Feb.
Nation’s largest cancer magazine reports on beloved television host’s experiences, guidance for others. Plainsboro, NJ (PRWEB) February 05, 2015
Analysis of Phase I Trial indicates Safety and positive immune response data in 21 of 21 patients administered Folate Receptor Alpha Vaccine for breast and ovarian cancers SEATTLE,
- a slit in a tire to drain away surface water and improve traction.